Delivery Order SPE2DB25D3108-SPE2DB25FPDQQ
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count units) under a firm fixed-price contract. The award, made on September 9, 2025, carries a ceiling value of $5,139.87 with an ultimate completion date of September 10, 2025. This non-set-aside, competitively awarded delivery order represents a small-value pharmaceutical transaction supporting federal medical supply chain requirements. AmerisourceBergen...
- The Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp valued at $11,144.50 for the supply of Jardiance 25 mg tablets (90-count units). This is a firm fixed-price delivery order with an ultimate completion date of August 19, 2025, and represents a non-competitive set-aside award. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office location in...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $22,664.02 to AmerisourceBergen Drug Corp for the supply of Jardiance 10 mg tablets (90-count packages) under a firm fixed-price contract. The award was issued on September 8, 2025, with an ultimate completion date of September 9, 2025, and represents a non-set-aside, competitively awarded procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor...
- The Defense Logistics Agency awarded a delivery order valued at $17,792.15 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count packages) on September 19, 2025, with an ultimate completion date of September 22, 2025. This competitively awarded, firm fixed-price contract represents a non-set-aside procurement for pharmaceutical products to support federal medical supply needs. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in...
- The Defense Logistics Agency awarded a delivery order valued at $14,076.88 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count units) on August 28, 2025, with an ultimate completion date of August 29, 2025. This competitively awarded, firm fixed-price delivery order is non-set-aside and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare...
- The Defense Logistics Agency awarded a delivery order valued at $18,140.70 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count units) under a firm fixed price contract type. This competitive award, issued on August 28, 2025, with an ultimate completion date of August 29, 2025, carries no set-aside designation. The pharmaceutical products will be delivered to Conshohocken, Pennsylvania, the location of AmerisourceBergen's corporate office and primary distribution...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $58,364.49 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count packages) under a firm fixed price contract. The award was issued on September 16, 2025, with an ultimate completion date of September 17, 2025, and involves delivery to Conshohocken, Pennsylvania. This competitive award includes no set-aside designation and represents a continuation of AmerisourceBergen's role as a critical...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for $43,652.08 to supply Jardiance 25 mg tablets (90-count units) under a firm fixed price contract. The award was issued on May 22, 2025, with an ultimate completion date of May 23, 2025, and represents a non-set-aside competitive award. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is a child contract executed under AmerisourceBergen's...
- The Defense Logistics Agency (DLA) awarded a $47,507.24 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count units) to be delivered by September 10, 2025. This non-set-aside competitive award leverages AmerisourceBergen's position as a critical pharmaceutical distributor supporting federal medical procurement needs. The contract was awarded on September 9, 2025, with performance at AmerisourceBergen's Conshohocken, Pennsylvania...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $15,489.84 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count units) under a firm fixed-price contract. This competitively awarded, non-set-aside delivery order was executed on September 11, 2025, with an ultimate completion date of September 12, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a continuation of...
- SPE2DB25D3108Indefinite Delivery Contract
- SPE2DB25D3108-SPE2DB25FPDQQDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $19,146.61 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count units) under a firm fixed-price contract. The award was made on August 14, 2025, with an ultimate completion date of August 15, 2025, and represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is performing this order from its corporate office location in the same city. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. The prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling the contractor to supply a diverse range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. AmerisourceBergen Drug Corp's extensive federal contract portfolio demonstrates its established capability as a critical pharmaceutical distributor serving defense and veteran healthcare systems through competitively awarded agreements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $19.1k | 8/14/25 |